[Mechanism of action of new sympathomimetics (dopamine and wyamine) and the ir therapeutic possibilities in cardiogenic shock].
作者信息
Döring D
出版信息
Z Gesamte Inn Med. 1971 Jul 1;26(13):Suppl:170-2.
PMID:5125156
Abstract
摘要
相似文献
1
[Mechanism of action of new sympathomimetics (dopamine and wyamine) and the ir therapeutic possibilities in cardiogenic shock].
Z Gesamte Inn Med. 1971 Jul 1;26(13):Suppl:170-2.
2
Evaluation of the pharmacologic basis for the therapy of circulatory shock.循环性休克治疗的药理学基础评估。
Am J Cardiol. 1970 Dec;26(6):570-7. doi: 10.1016/0002-9149(70)90409-1.
3
Indications for adrenergic stimulators in shock.休克时肾上腺素能兴奋剂的适应证。
Int Z Klin Pharmakol Ther Toxikol. 1971 Jun;4(4):385-95.
4
[Use of alpha- and beta-adrenomimetics in the intensive therapy of traumatic and cardiogenic shock and their effect on the blood circulation].
Anesteziol Reanimatol. 1988 Nov-Dec(6):24-7.
5
Treatment of cardiac shock by metaraminol.间羟胺治疗心源性休克。
Br Med J. 1959 Apr 25;1(5129):1081-3. doi: 10.1136/bmj.1.5129.1081.
6
[Drug therapy in cardiogenic shock].
Int J Clin Pharmacol. 1973 Apr;7(2):127-31.
7
8
Use of sympathomimetic amines in shock.拟交感神经胺在休克中的应用。
Am Fam Physician. 1974 Jul;10(1):80-5.
9
Pharmacology of pressor agents on the systemic circulation.升压药对体循环的药理学作用。
Semin Drug Treat. 1973 Winter;3(3):231-40.
10
[Influencing of the kidney function by new sympathomimetics].[新型拟交感神经药对肾功能的影响]
Z Gesamte Inn Med. 1971 Jul 1;26(13):Suppl:175-6 c.
Zotero 插件